Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV

Virology

Volumn 251, Issue 1, 1998, Pages 206-214

  Jin, Hong ^a   Clarke, David ^a   Zhou, Helen Z Y ^a   Cheng, Xing ^a   Coelingh, Kathleen ^a   Bryant, Martin ^a   Li, Shengqiang ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE STRUCTURE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEQUENCE ANALYSIS; VACCINE PRODUCTION; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME;

ANIMALIA; DNA VIRUSES; HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SUBGROUP A; SUBGROUP B; SYNCYTIAL VIRUS;

EID: 0032506277     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9414     Document Type: Article

References (38)

1. Beeler J. A., van Wyke Coelingh K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: Effect of mutation upon fusion function. J. Virol. 63:1989;2941-2950.
2. Bukreyev A., Camargo E., Collins P. L. Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J. Virol. 70:1996;6634-6641.
3. Bukreyev A., Whitehead S. S., Murphy B. R., Collins P. L. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71:1997;8973-8982.
4. Calain P., Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:1993;4822-4830.
5. Chin J., Magoffin R. L., Shearer L. A., Schieble J. H., Lennette E. H. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:1969;449-463.
6. Collins P. L., Hill M. G., Camargo E., Grosfeld H., Chanock R. M., Murphy B. R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
7. Collins P. L., Hill M. G., Cristina J., Grosfeld H. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc. Natl. Acad. Sci. USA. 93:1996;81-85.
8. Collins P. L., Mink M. A., Hill M. G., Camargo E., Grosfeld H., Stec D. S. Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA. Virology. 195:1993;252-256.
9. Conzelmann K. K. Genetic manipulation of non-segmented negative-strand RNA viruses. J. Gen. Virol. 77:1996;381-389.
10. Crowe J. Jr., Bui P. T., London W. T., Davis A. R., Hung P. P., Chanock R. M., Murphy B. R. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine. 12:1994;691-699.
11. Gharpure M. A., Wright P. F., Chanock R. M. Temperature-sensitive mutants of respiratory syncytial virus. J. Virol. 3:1969;414-421.
12. Grosfeld H., Hill M. G., Collins P. L. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J. Virol. 69:1995;5677-5686.
13. Hardy R. W., Wertz G. W. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J. Virol. 72:1998;520-526.
14. He B., Paterson R. G., Ward C. D., Lamb R. A. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology. 237:1997;249-260.
15. Hodes D. S., Kim H. W., Parrott R. H., Camargo E., Chanock R. M. Genetic alteration in a temperature-sensitive mutant of respiratory syncytial virus after replicationin vivo. Proc. Soc. Exp. Biol. Med. 145:1974;1158-1164.
16. Hoffman M. A., Banerjee A. K. An infectious clone of human parainfluenza virus type 3. J. Virol. 71:1997;4272-4277.
17. Jin H., Leser G. P., Zhang J., Lamb R. A. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J. 16:1997;1236-1247.
18. Juhasz, K. Whitehead, S. S. Bui, P. T. Biggs, J. M. Crowe, J. E. Boulanger, C. A. Collins, P. L. Murphy, B. R. 1997, The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein, J. Virol. 71, 8953, J. Virol. 71, 5814, 5819.
19. Juhasz, K. Whitehead, S. S. Bui, P. T. Biggs, J. M. Crowe, J. E. Boulanger, C. A. Collins, P. L. Murphy, B. R. 1997, The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein, J. Virol. 71, 8953, J. Virol. 71, 5814, 5819.
20. Kapikian A. Z., Mitchell R. H., Chanock R. M., Shvedoff R. A., Stewart C. E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:1969;405-421.
21. Karron R. A., Buonagurio D. A., Georgiu A. F., Whitehead S. S., Adamus J. E., Clements-Mann M. L., Harris D. O., Randolph V. B., Udem S. A., Murphy B. R., Sidhu M. S. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replicationin vitro. Proc. Natl. Acad. Sci. USA. 94:1997;13961-13966.
22. Kim H. W., Arrobio J. O., Brandt C. D., Wright P., Hodes D., Chanock R. M., Parrott R. H. Safety and antigenicity of temperature sensitive (ts) mutant respiratory syncytial virus (RSV) in infants and children. Pediatrics. 52:1973;56-63.
23. Kretzschmar E., Buonocore L., Schnell M. J., Rose J. K. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J. Virol. 71:1997;5982-5989.
24. Lamb R. A., Kolakofsky D. Paramyxoviridae: The viruses and their replication. Fields Virology. 1996;Raven Press, New York.
25. McIntosh K., Chanock R. M. Respiratory syncytial virus. Knipe D. M. Virology. 1990;Raven Press, Ltd, New York.
26. Palese P., Zheng H., Engelhardt O. G., Pleschka S., Garcia-Sastre A. Negative-strand RNA viruses: Genetic engineering and applications. Proc. Natl. Acad. Sci. USA. 93:1996;11354-11358.
27. Perrotta A. T., Been M. D. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature. 350:1991;434-436.
28. Roberts A., Rose J. K. Recovery of negative-strand RNA viruses from plasmid DNAs: A positive approach revitalizes a negative field. Virology. 247:1998;1-6.
29. Roberts S. R., Lichtenstein D., Ball L. A., Wertz G. W. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J. Virol. 68:1994;4538-4546.
30. Samal S. K., Collins P. L. RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral triucleotide extension at the leader end. J. Virol. 70:1996;5075-5082.
31. Singh M., Hangartner L., Cornu T., Christiansen G., Billeter M. A. Measles virus as a vector system. 10th International Conference on Negative Strand Viruses, Dublin, Ireland. 1997.
32. Spielhofer P., Bachi T., Fehr T., Christiansen G., Cattaneo R., Kaelin K., Billeter M. A., Naim H. Y. Chimeric measles viruses with a foreign envelope. J. Virol. 72:1998;2150-2159.
33. Storch G. A., Park C. S. Nonoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus. J. Med. Virol. 22:1987;345-356.
34. Sutter G., Ohlmann M., Erfle V. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett. 371:1995;9-12.
35. Whitehead S. S., Juhasz K., Firestone C. Y., Collins P. L., Murphy B. R. Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees. J. Virol. 72:1998;4467-4471.
36. Wright P. F., Shinozaki T., Fleet W., Sell S. H., Thompson J., Karzon D. T. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J. Pediatr. 88:1976;931-936.
37. Wyatt L. S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology. 210:1995;202-205.
38. Yu Q., Hardy R. W., Wertz G. W. Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J. Virol. 69:1995;2412-2419.